搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

  1. 首頁
  2. 試劑盒
  3. 酶聯(lián)免疫試劑盒
  4. Rat peroxisome proliferators activator receptors alpha,PPAR-α ELISA Kit

Rat peroxisome proliferators activator receptors alpha,PPAR-α ELISA Kit

  • 中文名稱：
    大鼠過氧化物酶體增殖物激活受體α(PPAR-α)酶聯(lián)免疫試劑盒
  • 貨號：
    CSB-E09755r
  • 規(guī)格：
    96T/48T
  • 價格：
    ￥3900/￥2500
  • 其他：

產(chǎn)品詳情

  • 產(chǎn)品描述：
    大鼠過氧化物酶體增殖物激活受體α(PPAR-α)酶聯(lián)免疫試劑盒（CSB-E09755r）為雙抗夾心法ELISA試劑盒，定量檢測血清、血漿、組織勻漿、細胞裂解物樣本中的PPARA含量。PPARA，即過氧化物酶體增殖物激活受體α，是一種核受體，主要在肝臟、心肌、腎臟和骨骼肌等組織中表達。它參與調(diào)節(jié)能量代謝、氧化應激和炎癥等多種生物活動，與動脈粥樣硬化、冠心病、心肌梗死和心力衰竭等疾病密切相關(guān)。PPARA的研究機制涉及其與YAP-TEAD信號通路相互作用，促進肝增大和肝再生，以及通過調(diào)節(jié)血脂代謝和炎癥反應來影響心血管疾病的發(fā)生發(fā)展。試劑盒檢測范圍為0.312 ng/mL-20 ng/mL，適用于體外培養(yǎng)細胞、實驗動物模型等科研場景中PPAR-α蛋白表達水平的動態(tài)監(jiān)測，可支持脂代謝調(diào)控機制探索、藥物干預效果評估等基礎(chǔ)研究。本品僅用于科研，不用于臨床診斷，產(chǎn)品具體參數(shù)及操作步驟詳見產(chǎn)品說明書。
  • 別名：
    Ppara ELISA Kit; Nr1c1 ELISA Kit; Ppar ELISA Kit; Peroxisome proliferator-activated receptor alpha ELISA Kit; PPAR-alpha ELISA Kit; Nuclear receptor subfamily 1 group C member 1 ELISA Kit
  • 縮寫：
  • Uniprot No.：
  • 種屬：
    Rattus norvegicus (Rat)
  • 樣本類型：
    serum, plasma, tissue homogenates, cell lysates
  • 檢測范圍：
    0.312 ng/mL-20 ng/mL
  • 靈敏度：
    0.078 ng/mL
  • 反應時間：
    1-5h
  • 樣本體積：
    50-100ul
  • 檢測波長：
    450 nm
  • 研究領(lǐng)域：
    Metabolism
  • 測定原理：
    quantitative
  • 測定方法：
    Sandwich
  • 精密度：
    Intra-assay Precision (Precision within an assay): CV%<8%
    Three samples of known concentration were tested twenty times on one plate to assess.
    Inter-assay Precision (Precision between assays): CV%<10%
    Three samples of known concentration were tested in twenty assays to assess.
  • 線性度：
    To assess the linearity of the assay, samples were spiked with high concentrations of rat PPAR-α in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
    　SampleSerum(n=4)
    1:1Average %96
    Range %89-100
    1:2Average %94
    Range %88-98
    1:4Average %96
    Range %91-100
    1:8Average %95
    Range %87-101
  • 回收率：
    The recovery of rat PPAR-α spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample TypeAverage % RecoveryRange
    Serum (n=5) 9286-96
    EDTA plasma (n=4)9085-96
  • 標準曲線：
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    ng/mlOD1OD2AverageCorrected
    202.183 2.177 2.180 2.068
    101.654 1.627 1.641 1.529
    51.240 1.211 1.226 1.114
    2.50.859 0.842 0.851 0.739
    1.250.546 0.513 0.530 0.418
    0.6250.381 0.373 0.377 0.265
    0.3120.166 0.157 0.162 0.050
    00.111 0.113 0.112 　
  • 數(shù)據(jù)處理：
  • 貨期：
    3-5 working days

產(chǎn)品評價

靶點詳情

  • 功能：
    Ligand-activated transcription factor. Key regulator of lipid metabolism. Activated by the endogenous ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Activated by oleylethanolamide, a naturally occurring lipid that regulates satiety. Receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the ACOX1 and P450 genes. Transactivation activity requires heterodimerization with RXRA and is antagonized by NR2C2. May be required for the propagation of clock information to metabolic pathways regulated by PER2.
  • 基因功能參考文獻：
    1. MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha expression in cardiorenal syndrome type 4, to alter cardiac pathology. PMID: 28760335
    2. The results suggested that PPARalpha activation may exert a protective effect against ischemia/reperfusion in the myocardium, at least in part via endoplasmic reticulum stress inhibition. PMID: 29568903
    3. Repeated activation of PPARalpha induced a decreased phosphorylation of beta2*nAChRs that was accompanied by a switch in firing pattern of spontaneously active dopamine cells. PPARalpha activation enhanced dopamine D1 receptor signaling in the nucleus accumbens shell (NAcS). Long-term PPARalpha stimulation restored dopamine signaling to sucrose consumption in the NAcS and appetitive motivation. PMID: 27457507
    4. findings unravel the mechanism of Arjunolic acid action in regressing hypertrophy-associated cardiac fibrosis by assigning a role of Arjunolic acid as a PPARalpha agonist that inactivates non-canonical TGF-beta signaling. PMID: 28821620
    5. Roux-en-Y gastric bypass upregulates striatal dopamine 1 receptor (D1R) expression specifically under high-fat diet feeding conditions. PMID: 28065827
    6. Metabolism of methiocarb and carbaryl alters PPAR alpha agonist activity. PMID: 27665777
    7. Ultraviolet absorber, 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole exerts its hepatotoxicity through the PPARalpha signal pathway and the sex-related difference in PPARalpha expression may contribute to the sex-related difference in susceptibility to hepatotoxicity. PMID: 27665778
    8. Suggest the therapeutic effects of berberine on angiotensin IV-induced proliferation in cultured vascular smooth muscle cells are partially partially mediated by the PPARalpha-NO signalling pathway. PMID: 27927051
    9. PPARalpha-stimulation prevents overexpression of pro-inflammatory molecules in a model of acute myocardial infarction. PMID: 27050838
    10. UA inhibited the exaggerated spinal cord inflammatory response to peripheral inflammatory stimulation in HFDinduced obesity by restoring downregulated spinal PPARalpha, preventing peripheral inflammation and inflammatory hyperalgesia. PMID: 27108888
    11. PPAR-alpha-FGF21 induction by docosahexaenoic acid (DHA) and thyroid hormone (T3) may involve ligand activation of PPAR-alpha by DHA and enhanced expression of PPAR-alpha by T3. PMID: 27248050
    12. the results confirm the relation between the development of insulin-resistance with the over-expression of SREBP-1c, the reduction of PPAR-alpha expression and the predominance of large and triglyceride over-enriched VLDL circulating particles. PMID: 25796423
    13. GW0742 has the ability to improve glucose homeostasis in diabetic rats through activation of PPAR-delta. PMID: 26508837
    14. Stimulation of PPAR-alpha by medium chain triglycerides promotes reverse cardiac remodeling in chronic pressure overload. PMID: 25976666
    15. Age-related sensitivity to endotoxin-induced liver inflammation is mediated by IL-1beta-induced lipid accumulation in hepatocytes through the dysregulation of PPARa and SREBP1c. PMID: 25847140
    16. Fructose feeding significantly decreased mRNA levels for PPAR alpha and CPT1A. PMID: 26519879
    17. Data suggest that expression of PPARA in liver can be regulated by dietary factors; here, dietary supplementation with 5-caffeoylquinic acid up-regulates expression of PPARA and prevents high-fat diet induced obesity. PMID: 25186103
    18. Stimulation of PPARalpha by clofibrate prevents an increase in the activity of renin-angiotensin system and promotes the production of vasodilator substances in myocardial ischemia. PMID: 25658458
    19. Tau supplementation prevented obesity and hepatic TG deposition by upregulating MTP mRNA, ameliorating hepatic lipid efflux, and consequently enhancing PPAR-alpha which increases lipid oxidation through ACO and CPT-1a gene expressions. PMID: 26092479
    20. Findings suggest that diet-induced obesity causes down-regulation of spinal PPARalpha, which facilitates the susceptibility to peripheral inflammatory challenge by increasing inflammatory response in the spinal cord. PMID: 25135355
    21. results demonstrate that inhibition of PPARalpha attenuates the beneficial effects of metformin on mitochondria in acute IR. PMID: 22837722
    22. In cardiomyocytes the protective effects of metformin-induced AMPK activation against oxidative stress converge on mitochondria and are mediated, at least in part, through the dissociation of PPARalpha-CypD interactions. PMID: 25617357
    23. the phosphorylation of ERK1/2 inhibited the expression and activity of SCAD through the PPARalpha signaling pathway, which induced the development of pathological cardiomyocyte hypertrophy. PMID: 25636810
    24. PPARalpha contributes to regulation of blood pressure and vascular reactivity in SHR, and clofibrate-mediated reduction in blood pressure and proteinuria is probably through increased NO production. PMID: 24562305
    25. data uncover HILPDA as a novel PPAR target that raises hepatic triglyceride storage via regulation of triglyceride secretion. PMID: 24876382
    26. Peroxisomal multifunctional enzyme type 1 (rpMFE-1) undergoes Posttranslational Modification on several N epsilon-Lys residues under PPAR-alpha-mediated peroxisome proliferation. [peroxisomal multifunctional enzyme type 1] PMID: 24092543
    27. Systemic disorganization of functional activity of nuclear PPAR plays a key role in the molecular mechanisms of metabolic and immune disturbances in rats with inherited stress-induced arterial hypertension. PMID: 24288751
    28. These findings unveil novel roles for PPARalpha in mediating stress signals between hepatic subcellular stress-responding machinery PMID: 24735884
    29. After spinal cord injury, there is a long-lasting in the level of PPARalpha in white matter in the vicinity of the lesion site. PMID: 23958344
    30. Urotensin-II can protect renal tubular cells from apoptosis through PGI2-mediated PPARA and Akt activation. PMID: 23933501
    31. A decrease in the expression of Nrf2 and PPARalpha, together with an increase in NF-kappaB expression, was observed in the renal cortex of L-NAME-induced hypertensive rats compared with control rats. PMID: 23223967
    32. PPAR signaling pathway is activated following ethyl tertiary-butyl ether administration which leads to tumorigenesis. PMID: 24090815
    33. glomerular hypertrophic responses in rats on a HFD are associated with reduced PPARdelta expression and increased p38 MAPK phosphorylation. PMID: 23592661
    34. Growing evidence points to PPARalpha as an additional detector of metabolic signals and altered functional demands, able to set into motion prompt responses to cope with ongoing metabolic needs and maintain cell homeostasis. PMID: 23394525
    35. in ischemia-reperfusion, functional interplay between the decrease in L-carnitine and the PPARalpha/PGC1alpha pathway-induced redirection of fatty acid metabolism protects mitochondria against long chain fatty acid overload PMID: 23525500
    36. novel differences in the regulation of lipins 1,2,3, PPARalpha, and PGC-1alpha splice variants during fasting in heart versus liver, even though the ultimate outcome in both tissues is to increase FA turnover and oxidation. PMID: 23505321
    37. The hypocholesterolemic functions of chlorogenic acid are probably due to the increase in fatty acids unitization in liver via the up-regulation of peroxisome proliferation-activated receptor alpha mRNA. PMID: 22674675
    38. Activation of PPAR-alpha played a protective role in acute pancreatitis, partially mediated by modulation of TLR pathways. PMID: 22722259
    39. PPARalpha plays a role in the regulation of the ubiquitin proteasome system. PMID: 23041501
    40. PPARalpha significantly contributes to the effects of endogenous cholinergic transmission mediated by ss2-nicotinic acetylcholine receptors on dopamine (DA) neuron excitability and to the effects of nicotine on locomotor activity, a DA associated behavior. PMID: 20570248
    41. PPARalpha activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats. PMID: 22245887
    42. Pharmacological activation of PPARalpha improves metabolic milieu, steatosis, ballooning, and combats NF-kappaB and JNK activation, neutrophil and F4/80 macrophage recruitment in diabetes-related NASH. PMID: 21929649
    43. Peroxisome proliferator-activated receptor-gamma regulates inflammation and renin-angiotensin system activity in the hypothalamic paraventricular nucleus and ameliorates peripheral manifestations of heart failure. PMID: 22083161
    44. PPARalpha can compete with GATA-4 binding to NFATc4 PMID: 22198280
    45. Abnormal expressions of FXR and PPARa may play a role in pathogenesis of estrogen-induced intrahepatic cholestasis. PMID: 21205480
    46. findings suggest that increased PPAR-alpha expression in OLETF rats liver is a contributory factor to the exercise-related improvements in whole-body metabolism. PMID: 21618160
    47. Integrated investigation of PPAR, LXR, PXR, CAR regulatory mechanisms, signal transduction and transcriptional targets will provide insights into the pathogenesis of MS and offer valuable information for designing of drugs for MS treatment. PMID: 22066269
    48. Evidence indicating the involvement of the saturated acylethanolamide palmitoylethanolamide in allopregnanolone synthesis through PPAR-alpha in astrocytes. PMID: 21554431
    49. Activation of PPARalpha protects cells in dentate gyrus and hippocampus from excitotoxic insult. PMID: 20221904
    50. Upregulation of apoA5 expression contributes to the triglyceridelowering effect of statins via the PPARalpha signaling pathway. PMID: 21092650

    顯示更多

    收起更多

  • 亞細胞定位：
    Nucleus.
  • 蛋白家族：
    Nuclear hormone receptor family, NR1 subfamily
  • 組織特異性：
    Expressed predominantly in liver and kidney.
  • 數(shù)據(jù)庫鏈接：

    KEGG: rno:25747

    STRING: 10116.ENSRNOP00000038651

    UniGene: Rn.9753